Want to see AHG full AI Analyst Report?
Total Valuation
Akso Health Group Sponsored ADR has a market cap or net worth of $1.30B. The enterprise value is $105.45M.
Market Cap$1.30B
Enterprise Value$105.45M
Share Statistics
Akso Health Group Sponsored ADR has 549,200,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding549,200,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akso Health Group Sponsored ADR’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -67.35%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-67.35%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee547.33K
Profits Per Employee-5.02M
Employee Count27
Asset Turnover0.07
Inventory Turnover79.16
Valuation Ratios
The current PE Ratio of Akso Health Group Sponsored ADR is ―. Akso Health Group Sponsored ADR’s PEG ratio is -0.37.
PE Ratio―
PS Ratio22.76
PB Ratio1.69
Price to Fair Value1.69
Price to FCF328.95
Price to Operating Cash Flow83.91
PEG Ratio-0.37
Income Statement
In the last 12 months, Akso Health Group Sponsored ADR had revenue of 14.78M and earned -134.98M in profits. Earnings per share was -0.48.
Revenue14.78M
Gross Profit-281.53K
Operating Income-166.30M
Pretax Income-166.27M
Net Income-134.98M
EBITDA-1.77M
Earnings Per Share (EPS)-0.48
Cash Flow
In the last 12 months, operating cash flow was 1.18M and capital expenditures -154.46K, giving a free cash flow of 1.02M billion.
Operating Cash Flow1.18M
Free Cash Flow1.02M
Free Cash Flow per Share<0.01
Dividends & Yields
Akso Health Group Sponsored ADR pays an annual dividend of $1.2, resulting in a dividend yield of ―
Dividend Per Share$1.2
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.28
52-Week Price Change26.67%
50-Day Moving Average1.68
200-Day Moving Average1.67
Relative Strength Index (RSI)52.55
Average Volume (3m)21.06K
Important Dates
Akso Health Group Sponsored ADR upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Akso Health Group Sponsored ADR as a current ratio of 14.20, with Debt / Equity ratio of 0.03%
Current Ratio14.20
Quick Ratio14.18
Debt to Market Cap0.00
Net Debt to EBITDA99.34
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Akso Health Group Sponsored ADR has paid -30.80M in taxes.
Income Tax-30.80M
Effective Tax Rate0.19
Enterprise Valuation
Akso Health Group Sponsored ADR EV to EBITDA ratio is -90.38, with an EV/FCF ratio of 156.71.
EV to Sales10.85
EV to EBITDA-90.38
EV to Free Cash Flow156.71
EV to Operating Cash Flow136.15
Balance Sheet
Akso Health Group Sponsored ADR has $176.23M in cash and marketable securities with $81.74K in debt, giving a net cash position of $176.15M billion.
Cash & Marketable Securities$176.23M
Total Debt$81.74K
Net Cash$176.15M
Net Cash Per Share$0.32
Tangible Book Value Per Share$0.63
Margins
Gross margin is -6.05%, with operating margin of -1125.37%, and net profit margin of -913.38%.
Gross Margin-6.05%
Operating Margin-1125.37%
Pretax Margin-1125.14%
Net Profit Margin-913.38%
EBITDA Margin-12.00%
EBIT Margin-26.55%
Analyst Forecast
The average price target for Akso Health Group Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast75.04%
EPS Growth Forecast-679.87%